{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:56:37Z","timestamp":1792788997208,"version":"4.5.0"},"reference-count":37,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2021,5,29]],"date-time":"2021-05-29T00:00:00Z","timestamp":1622246400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["Lu477\/23-1"],"award-info":[{"award-number":["Lu477\/23-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB 1009\/B02"],"award-info":[{"award-number":["SFB 1009\/B02"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"name":"IZKF","award":["ACSP 02"],"award-info":[{"award-number":["ACSP 02"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomolecules"],"abstract":"<jats:p>Influenza virus (IV) infections are considered to cause severe diseases of the respiratory tract. Beyond mild symptoms, the infection can lead to respiratory distress syndrome and multiple organ failure. Occurrence of resistant seasonal and pandemic strains against the currently licensed antiviral medications points to the urgent need for new and amply available anti-influenza drugs. Interestingly, the virus-supportive function of the cellular phosphatidylinositol 3-kinase (PI3K) suggests that this signaling module may be a potential target for antiviral intervention. In the sense of repurposing existing drugs for new indications, we used Pictilisib, a known PI3K inhibitor to investigate its effect on IV infection, in mono-cell-culture studies as well as in a human chip model. Our results indicate that Pictilisib is a potent inhibitor of IV propagation already at early stages of infection. In a murine model of IV pneumonia, the in vitro key findings were verified, showing reduced viral titers as well as inflammatory response in the lung after delivery of Pictilisib. Our data identified Pictilisib as a promising drug candidate for anti-IV therapies that warrant further studying. These results further led to the conclusion that the repurposing of previously approved substances represents a cost-effective and efficient way for development of novel antiviral strategies.<\/jats:p>","DOI":"10.3390\/biom11060808","type":"journal-article","created":{"date-parts":[[2021,5,31]],"date-time":"2021-05-31T00:22:15Z","timestamp":1622420535000},"page":"808","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Inhibition of Phosphatidylinositol 3-Kinase by Pictilisib Blocks Influenza Virus Propagation in Cells and in Lungs of Infected Mice"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4495-4052","authenticated-orcid":false,"given":"Stefanie","family":"Deinhardt-Emmer","sequence":"first","affiliation":[{"name":"Institute of Medical Microbiology, Jena University Hospital, Am Klinikum 1, D-07747 Jena, Germany"},{"name":"Section of Experimental Virology, Institute of Medical Microbiology, Center for Molecular Biomedicine (CMB), Jena University Hospital, Hans-Knoell-Str. 2, D-07745 Jena, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"J\u00e4ckel","sequence":"additional","affiliation":[{"name":"Institute of Virology Muenster, Centre for Molecular Biology of Inflammation (ZMBE), Westfaelische Wilhelms-University, D-48149 Muenster, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clio","family":"H\u00e4ring","sequence":"additional","affiliation":[{"name":"Section of Experimental Virology, Institute of Medical Microbiology, Center for Molecular Biomedicine (CMB), Jena University Hospital, Hans-Knoell-Str. 2, D-07745 Jena, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"B\u00f6ttcher","sequence":"additional","affiliation":[{"name":"Section of Experimental Virology, Institute of Medical Microbiology, Center for Molecular Biomedicine (CMB), Jena University Hospital, Hans-Knoell-Str. 2, D-07745 Jena, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janine J.","family":"Wilden","sequence":"additional","affiliation":[{"name":"Institute of Virology Muenster, Centre for Molecular Biology of Inflammation (ZMBE), Westfaelische Wilhelms-University, D-48149 Muenster, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Gl\u00fcck","sequence":"additional","affiliation":[{"name":"Section of Experimental Virology, Institute of Medical Microbiology, Center for Molecular Biomedicine (CMB), Jena University Hospital, Hans-Knoell-Str. 2, D-07745 Jena, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regine","family":"Heller","sequence":"additional","affiliation":[{"name":"Institute of Molecular Cell Biology, Center for Molecular Biomedicine (CMB), Jena University Hospital, Hans-Knoell-Str. 2, D-07745 Jena, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9163-5682","authenticated-orcid":false,"given":"Michaela","family":"Schmidtke","sequence":"additional","affiliation":[{"name":"Section of Experimental Virology, Institute of Medical Microbiology, Center for Molecular Biomedicine (CMB), Jena University Hospital, Hans-Knoell-Str. 2, D-07745 Jena, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirijam","family":"Koch","sequence":"additional","affiliation":[{"name":"Institute of Medical Microbiology, Jena University Hospital, Am Klinikum 1, D-07747 Jena, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bettina","family":"L\u00f6ffler","sequence":"additional","affiliation":[{"name":"Institute of Medical Microbiology, Jena University Hospital, Am Klinikum 1, D-07747 Jena, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4490-3052","authenticated-orcid":false,"given":"Stephan","family":"Ludwig","sequence":"additional","affiliation":[{"name":"Institute of Virology Muenster, Centre for Molecular Biology of Inflammation (ZMBE), Westfaelische Wilhelms-University, D-48149 Muenster, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8879-6087","authenticated-orcid":false,"given":"Christina","family":"Ehrhardt","sequence":"additional","affiliation":[{"name":"Section of Experimental Virology, Institute of Medical Microbiology, Center for Molecular Biomedicine (CMB), Jena University Hospital, Hans-Knoell-Str. 2, D-07745 Jena, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,5,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e201323","DOI":"10.1001\/jamanetworkopen.2020.1323","article-title":"Respiratory and Nonrespiratory Diagnoses Associated with Influenza in Hospitalized Adults","volume":"3","author":"Chow","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"3960","DOI":"10.1016\/j.vaccine.2018.05.057","article-title":"Economic burden of seasonal influenza in the United States","volume":"36","author":"Putri","year":"2018","journal-title":"Vaccine"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3389\/fmicb.2020.00135","article-title":"Broadly Protective Strategies against Influenza Viruses: Universal Vaccines and Therapeutics","volume":"11","author":"Vogel","year":"2020","journal-title":"Front. Microbiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.vaccine.2017.12.019","article-title":"How close are countries of the WHO European Region to achieving the goal of vaccinating 75% of key risk groups against influenza? Results from national surveys on seasonal influenza vaccination programmes, 2008\/2009 to 2014\/2015","volume":"36","author":"Jorgensen","year":"2018","journal-title":"Vaccine"},{"key":"ref_5","unstructured":"Duwe, S. (2017). Influenza viruses\u2014Antiviral therapy and resistance. GMS Infect. Dis., 5."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Fukao, K., Ando, Y., Noshi, T., Kitano, M., Noda, T., Kawai, M., Yoshida, R., Sato, A., Shishido, T., and Naito, A. (2019). Baloxavir marboxil, a novel cap-dependent endonuclease inhibitor potently suppresses influenza virus replication and represents therapeutic effects in both immunocompetent and immunocompromised mouse models. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0217307"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1800666","DOI":"10.2807\/1560-7917.ES.2019.24.3.1800666","article-title":"Assessing baloxavir susceptibility of influenza viruses circulating in the United States during the 2016\/17 and 2017\/18 seasons","volume":"24","author":"Gubareva","year":"2019","journal-title":"Eurosurveillance"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"a038513","DOI":"10.1101\/cshperspect.a038513","article-title":"The Two Sides of the Same Coin-Influenza Virus and Intracellular Signal Trans-duction","volume":"11","author":"Ludwig","year":"2019","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1111\/cmi.12108","article-title":"The NF-kappaB inhibitor SC75741 efficiently blocks influenza virus propagation and confers a high barrier for development of viral resistance","volume":"15","author":"Ehrhardt","year":"2013","journal-title":"Cell. Microbiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1111\/j.1462-5822.2007.00902.x","article-title":"Acetylsalicylic acid (ASA) blocks influenza virus propagation via its NF-kappaB-inhibiting activity","volume":"9","author":"Mazur","year":"2007","journal-title":"Cell. Microbiol."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Meineke, R., Rimmelzwaan, G.F., and Elbahesh, H. (2019). Influenza Virus Infections and Cellular Kinases. Viruses, 11.","DOI":"10.3390\/v11020171"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1111\/j.1462-5822.2009.01309.x","article-title":"A new player in a deadly game: Influenza viruses and the PI3K\/Akt signalling pathway","volume":"11","author":"Ehrhardt","year":"2009","journal-title":"Cell. Microbiol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1111\/j.1462-5822.2006.00713.x","article-title":"Bivalent role of the phosphatidylinositol-3-kinase (PI3K) during influenza virus infection and host cell defence","volume":"8","author":"Ehrhardt","year":"2006","journal-title":"Cell. Microbiol."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Eierhoff, T., Hrincius, E.R., Rescher, U., Ludwig, S., and Ehrhardt, C. (2010). The Epidermal Growth Factor Receptor (EGFR) Promotes Uptake of Influenza A Viruses (IAV) into Host Cells. PLoS Pathog., 6.","DOI":"10.1371\/journal.ppat.1001099"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Fujioka, Y., Tsuda, M., Hattori, T., Sasaki, J., Sasaki, T., Miyazaki, T., and Ohba, Y. (2011). The Ras\u2013PI3K Signaling Pathway Is Involved in Clathrin-Independent Endocytosis and the Internalization of Influenza Viruses. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0016324"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1462-5822.2010.01556.x","article-title":"Influenza A virus-induced early activation of ERK and PI3K mediates V-ATPase-dependent intracellular pH change required for fusion","volume":"13","author":"Marjuki","year":"2011","journal-title":"Cell. Microbiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1038\/nsmb847","article-title":"Novel roles of TLR3 tyrosine phosphorylation and PI3 kinase in double-stranded RNA signaling","volume":"11","author":"Sarkar","year":"2004","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1111\/j.1462-5822.2011.01680.x","article-title":"Phosphatidylinositol-3-kinase (PI3K) is activated by influenza virus vRNA via the pathogen pattern receptor Rig-I to promote efficient type I interferon production","volume":"13","author":"Hrincius","year":"2011","journal-title":"Cell. Microbiol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"14194","DOI":"10.1073\/pnas.0606109103","article-title":"Influenza A virus NS1 protein binds p85beta and activates phosphatidylinositol-3-kinase signaling","volume":"103","author":"Hale","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1128\/JVI.02082-06","article-title":"Influenza A Virus NS1 Protein Activates the PI3K\/Akt Pathway to Mediate Antiapoptotic Signaling Responses","volume":"81","author":"Ehrhardt","year":"2007","journal-title":"J. Virol."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Ros\u00e1rio-Ferreira, N., Preto, A., Melo, R., Moreira, I.S., and Brito, R.M.M. (2020). The Central Role of Non-Structural Protein 1 (NS1) in Influenza Biology and Infection. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21041511"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S1470-2045(16)00106-6","article-title":"Pictilisib for oestrogen receptor-positive, aromatase inhibitor-resistant, advanced or metastatic breast cancer (FERGI): A randomised, double-blind, placebo-controlled, phase 2 trial","volume":"17","author":"Krop","year":"2016","journal-title":"Lancet Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1158\/1078-0432.CCR-14-0947","article-title":"First-in-Human Phase I Study of Pictilisib (GDC-0941), a Potent Pan\u2013Class I Phosphatidylinositol-3-Kinase (PI3K) Inhibitor, in Patients with Advanced Solid Tumors","volume":"21","author":"Sarker","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1634\/theoncologist.2017-0090","article-title":"A Phase I Dose-Escalation Study of the Safety and Pharmacokinetics of Pictilisib in Combination with Erlotinib in Patients with Advanced Solid Tumors","volume":"22","author":"Leong","year":"2017","journal-title":"Oncologist"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"3670","DOI":"10.1158\/1078-0432.CCR-09-2828","article-title":"Predictive Biomarkers of Sensitivity to the Phosphatidylinositol 3\u2032 Kinase Inhibitor GDC-0941 in Breast Cancer Preclinical Models","volume":"16","author":"Wallin","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Seidel, N., Sauerbrei, A., Wutzler, P., and Schmidtke, M. (2014). Hemagglutinin 222D\/G Polymorphism Facilitates Fast Intra-Host Evolution of Pandemic (H1N1) 2009 Influenza A Viruses. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0104233"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.biosystems.2014.02.004","article-title":"Within-host influenza dynamics: A small-scale mathematical modeling approach","volume":"118","author":"Manchanda","year":"2014","journal-title":"Biosystems"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"7945","DOI":"10.1128\/JVI.77.14.7945-7956.2003","article-title":"The Ebola Virus VP35 Protein Inhibits Activation of Interferon Regulatory Factor 3","volume":"77","author":"Basler","year":"2003","journal-title":"J. Virol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"025012","DOI":"10.1088\/1758-5090\/ab7073","article-title":"Co-infection with Staphylococcus aureus after primary influenza virus infection leads to damage of the endothelium in a human alveolus-on-a-chip model","volume":"12","author":"Rennert","year":"2020","journal-title":"Biofabrication"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Deinhardt-Emmer, S., B\u00f6ttcher, S., H\u00e4ring, C., Giebeler, L., Henke, A., Zell, R., Jungwirth, J., Jordan, P.M., Werz, O., and Hornung, F. (2021). SARS-CoV-2 causes severe epithelial inflammation and barrier dysfunction. J. Virol.","DOI":"10.1101\/2020.08.31.276725"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"6541","DOI":"10.1002\/j.1460-2075.1996.tb01045.x","article-title":"Mechanism of activation of protein kinase B by insulin and IGF-1","volume":"15","author":"Alessi","year":"1996","journal-title":"EMBO J."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1126\/science.1106148","article-title":"Phosphorylation and regulation of Akt\/PKB by the rictor-mTOR complex","volume":"307","author":"Sarbassov","year":"2005","journal-title":"Science"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1128\/JVI.77.1.460-469.2003","article-title":"Whittaker, Role of protein kinase C \u03b2II in influenza virus entry via late endosomes","volume":"77","author":"Sieczkarski","year":"2003","journal-title":"J. Virol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"020421","DOI":"10.7189\/jogh.09.020421","article-title":"Global Seasonal Influenza-Associated Mortality Collaborator Network and GLaMOR Collaborating Teams. Global mortality associated with seasonal influenza epidemics: New burden estimates and predictors from the GLaMOR Project","volume":"9","author":"Paget","year":"2019","journal-title":"J. Glob. Health"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"6580","DOI":"10.1158\/1078-0432.CCR-17-0033","article-title":"The Phosphatidylinositol 3-Kinase Pathway as a Potential Therapeutic Target in Bladder Cancer","volume":"23","author":"Zeng","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s13058-018-1015-x","article-title":"A phase Ib study of pictilisib (GDC-0941) in combination with paclitaxel, with and without bevacizumab or trastuzumab, and with letrozole in advanced breast cancer","volume":"20","author":"Cresta","year":"2018","journal-title":"Breast Cancer Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"111718","DOI":"10.1016\/j.ejmech.2019.111718","article-title":"Phosphatidylinositol 3 kinase (PI3K) inhibitors as new weapon to combat cancer","volume":"183","author":"Elmenier","year":"2019","journal-title":"Eur. J. Med. Chem."}],"container-title":["Biomolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-273X\/11\/6\/808\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:10:25Z","timestamp":1760163025000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-273X\/11\/6\/808"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,29]]},"references-count":37,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2021,6]]}},"alternative-id":["biom11060808"],"URL":"https:\/\/doi.org\/10.3390\/biom11060808","relation":{},"ISSN":["2218-273X"],"issn-type":[{"value":"2218-273X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,29]]}}}